4.7 Article

Monitoring Thrombin Generation by Electrochemistry: Development of an Amperometric Biosensor Screening Test for Plasma and Whole Blood

期刊

CLINICAL CHEMISTRY
卷 55, 期 3, 页码 505-512

出版社

AMER ASSOC CLINICAL CHEMISTRY
DOI: 10.1373/clinchem.2008.111963

关键词

-

向作者/读者索取更多资源

BACKGROUND: Complete investigation of thrombophilic or hemorrhagic clinical presentations is a time-, apparatus-, and cost-intensive process. Sensitive screening tests for characterizing the overall function of the hemostatic system, or defined parts of it, would be very useful. For this purpose, we are developing an electrochemical biosensor system that allows measurement of thrombin generation in whole blood as well as in plasma. METHODS: The measuring system consists of a single-use electrochemical sensor in the shape of a strip and a measuring unit connected to a personal computer, recording the electrical signal. Blood is added to a specific reagent mixture immobilized in dry form on the strip, including a coagulation activator (e.g., tissue factor or silica) and an electrogenic substrate specific to thrombin. RESULTS: Increasing thrombin concentrations gave standard curves with progressively increasing maximal current and decreasing time to reach the peak. Because the measurement was unaffected by color or turbidity, any type of blood sample could be analyzed: platelet-poor plasma, platelet-rich plasma, and whole blood. The test strips with the predried reagents were stable when stored for several months before testing. Analysis of the combined results obtained with different activators allowed discrimination between defects of the extrinsic, intrinsic, and common coagulation pathways. Activated protein C (APC) predried on the strips allowed identification of APC-resistance in plasma and whole blood samples. CONCLUSIONS: The biosensor system provides a new method for assessing thrombin generation in plasma or whole blood samples as small as 10 mu L. The assay is easy to use, thus allowing it to be performed in a point-of-care settmg. (C) 2008 American Association for Clinical Chemistry

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Hematology

Pseudoreticulocytosis in a patient with myelodysplastic syndrome

Noemy De Rossi, Lorenzo Alberio, Gregoire Stalder

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Article Hematology

Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia

Matteo Marchetti, Stefano Barelli, Tobias Gleich, Francisco J. Gomez, Matthew Goodyer, Francesco Grandoni, Lorenzo Alberio

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Hematology

Combinations of rapid immunoassays for a speedy diagnosis of heparin-induced thrombocytopenia

Luana Rittener-Ruff, Matteo Marchetti, Elena Matthey-Guirao, Francesco Grandoni, Francisco J. Gomez, Lorenzo Alberio

Summary: This study evaluated the diagnostic performance of two rapid immunoassays in detecting heparin-induced thrombocytopenia and compared different diagnostic algorithms. The results showed that the Bayesian approach of sequentially using two rapid immunoassays was most effective in accurately diagnosing heparin-induced thrombocytopenia.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Biology

Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study

Vepusha Sathanantham, Lorenzo Alberio, Cedric Bovet, Pierre Fontana, Bernhard Gerber, Lukas Graf, Adriana Mendez, Thomas C. Sauter, Adrian Schmidt, Jan-Dirk Studt, Walter A. Wuillemin, Michael Nagler

Summary: PiCT is proposed as a reliable laboratory test for measuring direct oral anticoagulant drug levels, and it can accurately predict clinically relevant drug concentrations.

LIFE-BASEL (2022)

Letter Medicine, General & Internal

Long-standing thrombocytosis often precedes thromboembolic complications heralding the diagnosis of essential thrombocythemia

Gregoire Stalder, William Reis Da Silva, Amandine Segot, Sabine Blum, Francesco Grandoni, Lorenzo Alberio

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Article Hematology

Two novel platelet biotinylation methods and their impact on stored platelet concentrates in a blood bank environment

Charlotte Muret, David Crettaz, Agathe Martin, Alessandro Aliotta, Debora Bertaggia Calderara, Lorenzo Alberio, Michel Prudent

Summary: Two biotinylation methods were developed and compared in this study. The Bio-Direct method was found to be similar to standard PCs in terms of function and phenotype, making it more suitable for use in a blood bank environment.

TRANSFUSION (2022)

Review Medicine, General & Internal

How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass

Etienne Revelly, Emmanuelle Scala, Lorenzo Rosner, Valentina Rancati, Ziyad Gunga, Matthias Kirsch, Zied Ltaief, Marco Rusca, Xavier Bechtold, Lorenzo Alberio, Carlo Marcucci

Summary: Heparin-induced thrombocytopenia (HIT) is a severe adverse drug reaction in cardiac surgery involving heparin. It causes immune-mediated thrombocytopenia leading to thrombotic events. Anti-PF4/H antibodies and platelet aggregation tests confirm the diagnosis. Patients with HIT in cardiac surgery face high risks and specific challenges. An institutional protocol has been developed for managing HIT in different phases, including the use of non-heparin anticoagulants and potent antiplatelet drugs.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Caplacizumab for treating subacute intra-stent thrombus occurring despite efficacious double anti-platelet treatment and anticoagulation: a case report

Gregoire Stalder, Antoine Chatte, Noemy De Rossi, Patrick Yerly, Lorenzo Alberio, Eric Eeckhout

Summary: This article describes a rare complication of acute and subacute stent thrombosis, occurring in approximately 1.5% of patients treated with primary percutaneous intervention for ST-elevation myocardial infarction (STEMI). We present a case of a 58-year-old woman who experienced subacute stent thrombosis despite good stent expansion, dual antiplatelet therapy, and anticoagulation. Due to high von Willebrand factor (VWF) levels, N-acetylcysteine was administered to depolymerize VWF, but was not well tolerated. Caplacizumab was then used to prevent VWF from interacting with platelets, resulting in a favorable clinical and angiographic outcome.

EUROPEAN HEART JOURNAL-CASE REPORTS (2023)

Article Hematology

Thrombophilia and outcomes of venous thromboembolism in older patients

Marie Mean, Neal Breakey, Odile Stalder, Lorenzo Alberio, Andreas Limacher, Anne Angelillo-Scherrer, Pierre Fontana, Hans Jurg Beer, Nicolas Rodondi, Drahomir Aujesky, Bernhard Laemmle, Robert Escher

Summary: This study examined the prevalence of laboratory thrombophilic risk factors in elderly patients with VTE and their association with clinical outcomes. The results showed that 78% of patients had at least one risk factor, with elevated levels of various factors being the most common. The study also found significant associations between certain risk factors and VTE recurrence and death.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Letter Hematology

Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report

Mathilde Gavillet, Nathalie Rufer, Francesco Grandoni, Mattia Rizzi, Nicolas Vulliemoz, David Baud, Lorenzo Alberio, Giorgia Canellini, Helene Legardeur

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Letter Hematology

Comparative analysis of automated cell counts in oncological patients: Reliable results of point of care blood impedance measurements and pitfalls in myelodysplastic neoplasias and acute myeloid leukemias

Sabine Blum, Mariangela Costanza, Christine Coutaz, Olaia Naveiras, Olivier Spertini, Gerasimos Tsilimidos, Lorenzo Alberio

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2023)

Article Hematology

Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A

Debora Bertaggia Calderara, Rita Marchi Cappelletti, Ana Patricia Batista Mesquita Sauvage, Stephane Durual, Francisco J. Gomez, Maxime G. Zermatten, Alessandro Aliotta, Alessandro Casini, Lorenzo Alberio

Summary: This study found that global coagulation assays (GCA) can serve as indicators to monitor the biological response to non-factor replacement therapy, such as emicizumab. After treatment, PwHA patients showed improved coagulation activity and fibrin clot composition, although thrombin generation (TG) results remained slightly below the normal reference range. Remarkably, individual patients exhibited varying degrees of response to emicizumab, despite having similar plasma concentrations of the drug.

THROMBOSIS AND HAEMOSTASIS (2023)

Article Medicine, General & Internal

Visible-Light-Mediated Photocatalytic Deracemization

Laurence Bamps, Jean-Philippe Armenti, Mirela Bojan, Bruno Grandbastien, Christophe von Garnier, Renaud Du Pasquier, Florian Desgranges, Matthaios Papadimitriou-Olivgeris, Lorenzo Alberio, Martin Preisig, Jurg Schwitter, Benoit Guery

Summary: This study collected health complaints from 474 patients one year after COVID-19 diagnosis and found that age, comorbidity index, and smoking habits were associated with hospital admission. Patients with a history of thromboembolism before SARS-CoV-2 infection had a higher risk of recurrence of thromboembolism at 1 year. Fatigue was the most common neurologic symptom, followed by feeling slowed down, headache, and smell disturbance. COVID-19 patients scored higher in anxiety, depression, fatigue, and sleep measures compared to the healthy population.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator

Annika Burger, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Walter A. Wuillemin, Adrian Schmidt, Lukas Graf, Bernhard Gerber, Cedric Bovet, Thomas C. Sauter, Nikolaus B. Binder, Michael Nagler

Summary: The study tested the clinical performance of a universal anti-Xa assay using an edoxaban calibrator, which accurately determined the concentrations of all anti-Xa inhibitors. The assay showed a high sensitivity and specificity in predicting drug concentrations.

DIAGNOSTICS (2023)

Article Immunology

Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine

Lucrezia Mencarelli, Laura Moi, Natacha Dewarrat, Matteo Monti, Lorenzo Alberio, Maxime Ringwald, Karolina Swierdzewska, Antiochos Panagiotis, Camillo Ribi

Summary: This article describes a rare case of Eosinophilic Granulomatosis with Polyangiitis (EGPA) occurring after the mRNA-1273 vaccine in a young asthmatic woman. The temporal relationship between vaccination and EGPA onset is intriguing, although a causal relationship cannot be proven. Cases of inflammatory diseases in the context of vaccination remain rare.

VACCINES (2023)

暂无数据